Female premature coronary artery disease is influenced by traditional metabolic risk factors, sex-specific factors, and genetic predispositions, highlighting the need for sex-specific biomarkers.
Highlights the need for sex-specific biomarkers and multi-omics techniques to improve early detection and tailored treatment of premature coronary artery disease in women.
Absolute Event Rate: 0% vs 0%
Female PCAD is a complex condition influenced by a combination of traditional metabolic risk factors, sex-specific factors, and genetic predispositions. Sex-specific biomarkers and multi-omics techniques should be given top priority in future studies in order to improve early detection and tailored treatment.
Li et al. (Fri,) reported a other. Female premature coronary artery disease is influenced by traditional metabolic risk factors, sex-specific factors, and genetic predispositions, highlighting the need for sex-specific biomarkers.